跳至主要内容
临床试验/NCT04863963
NCT04863963已完成不适用

Milligan-Morgan Hemorrhoidectomy Versus Dearterialization With Mucopexy in the Treatment of Grade III Hemorrhoidal Disease: Multicenter Retrospective Study

Università degli Studi dell'Aquila1 个研究点 分布在 1 个国家目标入组 1,000 人开始时间: 2021年7月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
1,000
试验地点
1
主要终点
Speed in functional recovery

研究概览

简要总结

Nowadays, there are several methods that can be used for grade III hemorrhoidal disease, according to Goligher classificiation. Milligan Morgan hemorrhoidectomy is considered the most effective treatment in many centers, even if characterized by marked postoperative pain. Among the minimally invasive alternative procedures, the transanal hemorrhoidal dearterialization (HAL - ligation of the hemorrhoidal artery) Doppler-guided or without Doppler, associated with mucopexy, seems to gain success, with promising results but still awaiting high-grade scientific evidence.

On the basis of this background, we decided to carry out a multi-center survey on a national scale, retrospectively including patients diagnosed with Goligher's grade III hemorrhoidal disease, surgically treated with hemorrhoidectomy or dearterialization.

详细描述

The study will be of a multicentre observational retrospective type. Any Italian Center belonging to the Italian Society of Colorectal Surgery (SICCR) in which at least 30 procedures are performed per year for haemorrhoidal disease can join the study. Each Center must identify a Head of the study and a maximum of 2 collaborators. Each Center participating in the Study will be provided with a data collection sheet for completion. The information regarding the follow-up may come from a telephone survey or an outpatient clinical visit. In both cases, the patient will be asked to express informed consent by filling in the form attached to the information sheet.

The study will include patients treated with the analysed methods (Milligan Morgan or hemorrhoidal dearterialization) in the period comprising the 4 years prior to the adhesion of the center to the survey.

Patients included in the study will need to have at least 24 months of follow-up.

Given the inevitable effects of the SARS-CoV-2 pandemic on surgical and outpatient activities, the study period is considered valid until February 2020. Data regarding surgery or follow-up after March 2020 will not be included in analyzes.

The participation of 435 patients for each group is expected (870 total patients) considering a power of 80%, of which at least 50 in this facility, over the age of 18.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Other

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • ≥18 years-old
  • Goligher's grade III haemorrhoidal disease
  • indication to elective Doppler-guided or non-Doppler guided HAL surgery associated with mucopexy or Milligan-Morgan hemorrhoidectomy.

排除标准

  • Recurrent disease
  • bleeding disorders
  • chronic inflammatory bowel diseases
  • vasculopathies
  • combined surgical techniques (HAL with mucopexy and removal of one or more haemorrhoidal nodules)

结局指标

主要结局

Speed in functional recovery

时间窗: 24 months

Compare surgical techniques in terms of functional recovery

Rate of complications

时间窗: 24 months

Compare surgical techniques in terms of complications

Rate of choice of the two techniques

时间窗: 24 months

Evaluate the rate of choice in Italy of the two different surgical techniques (HAL THD with mucopexy and Milligan Morgan hemorrhoidectomy) for the treatment of Golighers's grade III hemorrhoidal disease

Effectiveness

时间窗: 24 months

Compare surgical techniques in terms of effectiveness (persistence / reappearance of symptoms and recurrences).

次要结局

  • Type of anesthesia(24 months)
  • Hospitalization times(24 months)
  • Surgical device(24 months)

研究者

发起方
Università degli Studi dell'Aquila
申办方类型
Other
责任方
Principal Investigator
主要研究者

Lucia Romano

Principal Investigator

Università degli Studi dell'Aquila

研究点 (1)

Loading locations...

相似试验